J. Muhlestein

J. Muhlestein, G. Rodgers, W. Barry, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

GENE THERAPY IN CARDIOVASCULAR DISEASE: DIRECT IN VIVO GENE TRANSFER INTO THE V ASCULA TURE

J. Muhlestein, G. Chapman, C. Lim, 1995 .

Prospective, Randomized, Multicenter Comparison of Laser-Facilitated Balloon Angioplasty Versus Stand-Alone Balloon Angioplasty in Patients With Obstructive Coronary Artery Disease fn1

J. Muhlestein, M. McIvor, D. Rizik, 2016 .

Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era.

D. Lappé, Jeffrey L. Anderson, J. Muhlestein, 2018, JCI insight.

Collaborative multidisciplinary workshop report: clinical antimicrobial trials for primary and secondary prevention of atherosclerotic cardiovascular disease.

R. Kronmal, J. Bartlett, H. Handsfield, 2000, The Journal of infectious diseases.

Randomized controlled trial of once-per-week intermittent fasting for health improvement: the WONDERFUL trial

Ciera L Bartholomew, B. Horne, H. May, 2021, European heart journal open.

with Increased Surgical Re-Exploration for Bleeding Early Postoperative Use of Unfractionated Heparin or Enoxaparin is Associated

B. Horne, D. Lappé, D. Renlund, 2013 .

Left ventricular assist device malfunction: an approach to diagnosis by echocardiography.

B. Horne, J. Muhlestein, J. Long, 2005, Journal of the American College of Cardiology.

Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease

Simon C. Potter, Thomas W. Mühleisen, Benjamin J. Wright, 2011, PLoS genetics.

C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

B. Horne, Jeffrey L. Anderson, J. Muhlestein, 2002, Journal of the American College of Cardiology.

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality.

B. Horne, R. Pearson, T. Bair, 2001, The American journal of cardiology.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

GLYCA AND GLYCB, NOVEL NMR BIOMARKERS OF INFLAMMATION, STRONGLY PREDICT FUTURE CARDIOVASCULAR EVENTS, BUT NOT THE PRESENCE OF CORONARY ARTERY DISEASE (CAD), AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

H. May, Jeffrey L. Anderson, M. Connelly, 2014 .

SUPPLEMENTING DEFICIENT VITAMIN D LEVELS IS ASSOCIATED WITH REDUCED CARDIOVASCULAR RISK

B. Horne, H. May, D. Lappé, 2010 .

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

H. May, D. Lappé, T. Bair, 2014, JAMA.

Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36.

B. Horne, J. Carlquist, J. Muhlestein, 2004, Atherosclerosis.

STATIN USE AT TIME OF RESPIRATORY VIRAL INFECTION IN PATIENTS WITH PRIOR HISTORY OF CARDIOVASCULAR DISEASE AND RISK OF SUBSEQUENT CARDIOVASCULAR EVENTS

B. Horne, J. Carlquist, T. Bair, 2015, Journal of the American College of Cardiology.

Short-term therapy with gatifloxacin or azithromycin prevents the acceleration of atherosclerosis after infection with Chlamydia Pneumoniaein a rabbit model but does not eradicate the organism form plaque

B. Horne, J. Carlquist, R. Pearson, 2003 .

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

Christopher M O'Connor, C. O'connor, M. Fisher, 2003, JAMA.

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.

J. Carlquist, J. Muhlestein, E. Hammond, 1998, Circulation.

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

B. Horne, D. Lappé, J. Carlquist, 2006, Journal of Thrombosis and Thrombolysis.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

Yan V. Sun, P. Deloukas, T. Lehtimäki, 2019, Circulation. Genomic and precision medicine.

1 Subsequent Event Risk in Individuals with Established Coronary Heart Disease : Design and Rationale of the GENIUS-CHD Consortium Running title :

Yan V. Sun, Ayman, Clara, 2019 .

Biomarkers of Infection and Risk of Coronary Heart Disease

J. Muhlestein, 2006 .

Chronic infection and coronary artery disease.

Jeffrey L. Anderson, J. Muhlestein, 2003, Cardiology clinics.

Chronic infection and coronary artery disease.

J. Muhlestein, Jeffrey L. Anderson, 2003, The Medical clinics of North America.

More Aggressive Left Atrial Ablation in Elderly Patients does not Increase Procedural Complications and Favorably Impacts Outcomes

H. May, D. Lappé, T. Bair, 2011 .

Long‐Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians

H. May, D. Lappé, T. Bair, 2010, Pacing and clinical electrophysiology : PACE.

Circulating Levels of Biomarkers of Cerebral Injury in Patients with Atrial Fibrillation.

Jeffrey L. Anderson, M. Cutler, J. Muhlestein, 2019, The American journal of cardiology.

A genome-wide meta-analysis uncovers six sequence variants conferring risk of vertigo

H. Stefánsson, D. Rujescu, D. Gudbjartsson, 2021, Communications Biology.

Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial

Nina P Paynter, Paul M Ridker, N. Paynter, 2015, European journal of preventive cardiology.

Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease.

B. Horne, H. May, Brianna S. Ronnow, 2007, The American journal of cardiology.

Association of periodic fasting with lower severity of COVID-19 outcomes in the SARS-CoV-2 prevaccine era: an observational cohort from the INSPIRE registry

B. Horne, H. May, T. Bair, 2022, medRxiv.

Intracardiac Ultrasound for Esophageal Anatomic Assessment and Localization During Left Atrial Ablation for Atrial Fibrillation

H. May, D. Lappé, T. Bair, 2013, Journal of cardiovascular electrophysiology.

A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction.

J. Carlquist, T. Bair, M. Todd, 1997, Journal of the American College of Cardiology.

Nickel elution properties of contemporary interatrial shunt closure devices.

J. Muhlestein, N. Rajasekaran, D. Verma, 2015, The Journal of invasive cardiology.

Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography.

B. Horne, H. May, D. Lappé, 2008, The American journal of cardiology.

Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography.

B. Horne, D. Lappé, Jeffrey L. Anderson, 2008, The American journal of cardiology.

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

B. Horne, H. May, D. Lappé, 2010, Heart rhythm.

The role of microRNAs in the development, regulation, and treatment of atrial fibrillation

M. Cutler, J. Muhlestein, K. Knowlton, 2019, Journal of Interventional Cardiac Electrophysiology.

Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide Therapy

H. May, T. Bunch, M. Cutler, 2021, Journal of cardiovascular pharmacology and therapeutics.

Atrial Fibrillation Significantly Increases Total Mortality and Stroke Risk Beyond that Conveyed by the CHADS2 Risk Factors

B. Horne, D. Lappé, T. Bunch, 2009, Pacing and clinical electrophysiology : PACE.

The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints

B. Horne, H. May, Brianna S. Ronnow, 2010, European journal of heart failure.

Frequency of elevation of C-reactive protein in atrial fibrillation.

B. Horne, D. Lappé, T. Bair, 2004, The American journal of cardiology.

Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation

H. May, T. Bair, T. Bunch, 2016, Journal of Interventional Cardiac Electrophysiology.

Warfarin Is Not Needed in Low‐Risk Patients Following Atrial Fibrillation Ablation Procedures

H. May, D. Lappé, T. Bair, 2009, Journal of cardiovascular electrophysiology.

A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: the apolipoprotein A1 remnant ratio (Apo A1/ [VLDL3+IDL])

B. Horne, H. May, T. Bair, 2013, Lipids in Health and Disease.

ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise

I. Piña, J. Messenger, V. Chair, 2013, Journal of the American College of Cardiology.

Antithrombotic Therapy in Patients with Acute Coronary Syndrome in the Intermountain Heart Collaborative Study

B. Horne, W. Klaskala, T. Bunch, 2015, Cardiology research and practice.

Warfarin Knowledge in Patients with Atrial Fibrillation: Implications for Safety, Efficacy, and Education Strategies

B. Horne, D. Lappé, Jeffrey L. Anderson, 2010, Cardiology.

Atrial Fibrillation and CHADS2 Risk Factors are Associated with Highly Sensitive C‐Reactive Protein Incrementally and Independently

B. Horne, D. Lappé, T. Bunch, 2009, Pacing and clinical electrophysiology : PACE.

Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population.

B. Horne, H. May, D. Lappé, 2010, The American journal of cardiology.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

Yan V. Sun, P. Deloukas, T. Lehtimäki, 2019, Circulation. Genomic and precision medicine.

Free thyroxine within the normal reference range predicts risk of atrial fibrillation

H. May, D. Lappé, T. Bair, 2020, Journal of cardiovascular electrophysiology.

Long-term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease.

H. May, T. Bair, T. Bunch, 2021, American heart journal.

CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation.

B. Horne, H. May, D. Lappé, 2019, Heart rhythm.

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

M L Woods, J. Carlquist, J. Muhlestein, 1996, Journal of the American College of Cardiology.

Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.

B. Horne, J. Carlquist, R. Pearson, 2003, American heart journal.

Intermittent fasting and changes in Galectin-3: A secondary analysis of a randomized controlled trial of disease-free subjects.

B. Horne, H. May, T. Bair, 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Health effects of intermittent fasting: hormesis or harm? A systematic review.

B. Horne, Jeffrey L. Anderson, J. Muhlestein, 2015, The American journal of clinical nutrition.

Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease.

B. Horne, H. May, J. Carlquist, 2013, The American journal of cardiology.

Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.

B. Horne, N. Camp, J. Carlquist, 2007, American heart journal.

Statin Therapy Interacts With Cytomegalovirus Seropositivity and High C-Reactive Protein in Reducing Mortality Among Patients With Angiographically Significant Coronary Disease

B. Horne, J. Carlquist, T. Bair, 2003, Circulation.

The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia).

J. Muhlestein, J. Anderson, 2000, The Journal of infectious diseases.

Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.

B. Horne, J. Carlquist, C. Nielson, 1999, Circulation.

Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences.

B. Horne, H. May, D. Lappé, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30‐day outcomes

J. L. Anderson, B. Horne, H. May, 2016, International journal of laboratory hematology.

Short‐Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST‐Segment Elevation Acute Coronary Events

C. Pope, B. Horne, Jeffrey L. Anderson, 2015, Journal of the American Heart Association.

Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay.

B. Horne, J. Carlquist, Jeffrey L. Anderson, 2006, American journal of clinical pathology.

Strategies to Increase HMG-CoA Reductase Inhibitor Use After Acute Myocardial Infarction

J. Muhlestein, 2004, Drugs & aging.

Restenosis after coronary intervention: narrowing C-reactive protein's prognostic potential?

Jeffrey L. Anderson, J. Muhlestein, 2003, The American journal of medicine.

Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience.

R. Califf, E. Topol, J. Muhlestein, 1999, American heart journal.

Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.

J. Muhlestein, W. Laskey, J. Hirshfeld, 2000, Circulation.

Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patients.

B. Horne, D. Renlund, R. Pearson, 2005, American heart journal.

Routine Stenting or Provisional Stenting: Which Is Better? A Look At Presently Existing Data

J. Muhlestein, C. Maycock, 1999 .

Toll-like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes.

B. Horne, J. Carlquist, T. Bair, 2004, American heart journal.

Impact of Selection Bias on Estimation of Subsequent Event Risk

P. Deloukas, T. Lehtimäki, D. Gudbjartsson, 2017, Circulation. Cardiovascular genetics.

Greater pathogen burden but not elevated C-reactive protein increases the risk of clinical restenosis after percutaneous coronary intervention.

B. Horne, J. Carlquist, T. Bair, 2002, American heart journal.

Antiplatelet agents in clinical practice: an economic perspective

J. Muhlestein, 1997 .

Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

B. Horne, T. Bair, Jeffrey L. Anderson, 2002, The American journal of cardiology.

Early effects of statins in patients with coronary artery disease and high C-reactive protein.

B. Horne, J. Carlquist, R. Pearson, 2004, The American journal of cardiology.

Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease.

B. Horne, J. Carlquist, T. Bair, 2000, Journal of the American College of Cardiology.

Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients.

B. Horne, J. Carlquist, R. Pearson, 2002, Journal of the American College of Cardiology.

Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease.

B. Horne, D. Lappé, D. Renlund, 2004, Annals of epidemiology.

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.

W. Kraus, B. Horne, Jeffrey L. Anderson, 2008, Journal of the American College of Cardiology.

Coronary artery plaque volume and obesity in patients with diabetes: the factor-64 study.

H. May, D. Lappé, Jeffrey L. Anderson, 2014, Radiology.

Cardiovascular Pharmacogenomics: Current Status, Future Prospects

J. Carlquist, Jeffrey L. Anderson, J. Muhlestein, 2003, Journal of cardiovascular pharmacology and therapeutics.

Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial

S. Oparil, W. Cushman, W. Kostis, 2017, Journal of hypertension.

Improvements in 1-Year Cardiovascular Clinical Outcomes Associated with a Hospital-Based Discharge Medication Program

Holly Rimmasch, Colleen Roberts, Janette Orton, 2004, Annals of Internal Medicine.

Genetics of coronary heart disease: current knowledge and research principles.

W. Kraus, C. Granger, B. Keavney, 2000, American heart journal.

An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction

B. Horne, J. Carlquist, J. Muhlestein, 2010, Journal of Thrombosis and Thrombolysis.

Improvement in the predictive ability of the Intermountain Mortality Risk Score by adding routinely collected laboratory tests such as albumin, bilirubin, and white cell differential count

B. Horne, H. May, Brianna S. Ronnow, 2016, Clinical chemistry and laboratory medicine.

Coronary Computed Tomography Angiography for Screening in Patients with Diabetes: Can Enhanced Detection of Subclinical Coronary Atherosclerosis Improve Outcome?

J. Muhlestein, F. L. Moreno, 2016, Current Atherosclerosis Reports.

Secondary prevention of coronary artery disease with antimicrobials: current status and future directions.

J. Muhlestein, 2002, American journal of cardiovascular drugs : drugs, devices, and other interventions.

trial fibrillation is independently associated with senile , ascular , and Alzheimer ’ s dementia

H. May, D. Lappé, Jeffrey L. Anderson, 2022 .

Primary Prevention of CVD: The Role of Imaging Trials.

D. Berman, J. Muhlestein, A. Rozanski, 2017, JACC. Cardiovascular imaging.

Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.

H. May, D. Lappé, J. Carlquist, 2016, The American journal of cardiology.

ANTICOAGULATION THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

B. Horne, W. Klaskala, T. Bunch, 2013 .

Impact of renal failure on the risk of myocardial infarction and death.

B. Horne, T. Bair, Jeffrey L. Anderson, 2002, Kidney international.

Ranolazine Reduces Patient-Reported Angina Severity and Frequency and Improves Quality of Life in Selected Patients with Chronic Angina

J. Muhlestein, S. Grehan, 2013, Drugs in R&D.

Hemochromatosis: Cardiac abnormalities in hemochromatosis

J. Muhlestein, 2000 .

Serum Uric Acid Independently Predicts Mortality in Patients with Significant, Angiographically Defined Coronary Disease

B. Horne, J. Carlquist, R. Pearson, 2005, American Journal of Nephrology.

The association of depression at any time to the risk of death following coronary artery disease diagnosis

B. Horne, H. May, D. Lappé, 2017, European heart journal. Quality of care & clinical outcomes.

UTILITY OF HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL, PARTICLE CONCENTRATION, AND SIZE IN PREDICTING FUTURE MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS UNDERGOING ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

H. May, Jeffrey L. Anderson, M. Connelly, 2014 .

Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.

M. Connelly, W. Boden, J. Muhlestein, 2018, Journal of clinical lipidology.

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis

H. May, D. Lappé, T. Bair, 2021, BMC Primary Care.

Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse.

Francesca N. Delling, M. Rienstra, B. Horne, 2022, European heart journal.

Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database.

B. Horne, N. Camp, L. Cannon-Albright, 2006, American heart journal.

Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?

B. Horne, D. Lappé, J. Carlquist, 2004, Cardiology.

Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy.

B. Horne, H. May, D. Lappé, 2011, Heart rhythm.

Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing.

B. Horne, D. Lappé, Jeffrey L. Anderson, 2019, The American journal of cardiology.

Economics and outcomes of sotalol in‐patient dosing approaches in patients with atrial fibrillation

H. May, T. Bair, J. Muhlestein, 2021, Journal of cardiovascular electrophysiology.

Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target

J. Carlquist, Jeffrey L. Anderson, J. Muhlestein, 2007, Expert review of molecular diagnostics.

ECONOMICS OF SOTALOL IN-PATIENT DOSING APPROACHES IN PATIENTS WITH ATRIAL FIBRILLATION

H. May, T. Bair, Jeffrey L. Anderson, 2020 .

The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.

B. Horne, J. Carlquist, T. Bair, 2003, American heart journal.

Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.

B. Horne, J. Carlquist, R. Pearson, 2005, American heart journal.

Effect of folic acid fortification of food on homocysteine-related mortality.

B. Horne, J. Carlquist, T. Bair, 2004, The American journal of medicine.

Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.

B. Horne, H. May, D. Renlund, 2006, American heart journal.

Association of Variation in the Chromosome 9p21 Locus With Myocardial Infarction Versus Chronic Coronary Artery Disease

B. Horne, J. Carlquist, T. Bair, 2008, Circulation. Cardiovascular genetics.

Transient neurological symptoms during contrast transcranial Doppler right-to-left shunt testing in patients with cryptogenic neurological disease.

J. Muhlestein, S. Sorensen, M. Goldstein, 2010, Journal of interventional cardiology.

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)

H. May, T. Bunch, M. Cutler, 2022, Journal of arrhythmia.

Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry

S. Pocock, T. Henry, S. Kapadia, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis

Andrew D. Johnson, Nicholette D. Palmer, Ansuman T. Satpathy, 2023, Nature.

Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop.

A. Khera, J. Min, Lawrence J. Fine, 2020, JACC. Cardiovascular imaging.

Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.

B. Horne, H. May, D. Lappé, 2021, American heart journal.

Rapid melting curve analysis for genetic variants that underlie inter-individual variability in stable warfarin dosing

B. Horne, H. May, J. Carlquist, 2008, Journal of Thrombosis and Thrombolysis.

Frequency and Outcomes of Patients Presenting with Non-ST Elevation Myocardial Infarction (NSTEMI) without Standard Modifiable Risk Factors: A US Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2023, Journal of clinical medicine.

Cardiovascular Outcomes of ST-Elevation Myocardial Infarction (STEMI) Patients without Standard Modifiable Risk Factors (SMuRF-Less): The Intermountain Healthcare Experience

H. May, T. Bair, J. Muhlestein, 2022, Journal of clinical medicine.

Usefulness of left atrial appendage volume as a predictor of embolic stroke in patients with atrial fibrillation.

B. Horne, Jeffrey L. Anderson, J. Muhlestein, 2013, The American journal of cardiology.

Smartphone ECG for evaluation of STEMI: results of the ST LEUIS Pilot Study.

Harry W Severance, J. Muhlestein, Jeffrey L. Anderson, 2015, Journal of electrocardiology.

The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severity

B. Horne, H. May, T. Bair, 2017, Psychology, health & medicine.

Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease.

B. Horne, N. Camp, J. Carlquist, 2010, American heart journal.

Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?

B. Horne, H. May, J. Carlquist, 2007, American heart journal.

Predictors of Statin Intolerance in Patients with a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Healthcare Institution: The IMPRES Study.

H. May, D. Lappé, T. Bair, 2020, Journal of cardiovascular pharmacology.

Usage patterns and 2‐year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry

D. Baim, J. Muhlestein, J. Lasala, 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Absence of Coronary Artery Calcium During Positron Emission Tomography Stress Testing in Patients Without Known Coronary Artery Disease Identifies Individuals With Very Low Risk of Cardiac Events

B. Horne, D. Lappé, Jeffrey L. Anderson, 2020, Circulation. Cardiovascular imaging.

Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.

H. May, D. Lappé, T. Bair, 2018, Journal of clinical lipidology.

Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation.

H. May, T. Bair, Jeffrey L. Anderson, 2021, The American journal of cardiology.

Endothelial dysfunction associated with drug-eluting stents what, where, when, and how?

J. Muhlestein, 2008, Journal of the American College of Cardiology.

INCIDENCE OF DEMENTIA IN RELATION TO GENETIC VARIANTS AT 4Q25 AND APOE ɛ4 IN ATRIAL FIBRILLATION PATIENTS

H. May, J. Carlquist, Jeffrey L. Anderson, 2013 .

The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.

B. Horne, L. Lazzeroni, J. Carlquist, 2005, Journal of cardiac failure.

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population

H. May, D. Lappé, T. Bair, 2020, ESC heart failure.

Myocardial Infarction Associated with Regional Myocardial Flow Deficit and Normal Coronary Arteries in a Patient with COVID-19: A Case Report

J. Muhlestein, K. Knowlton, Joel E Money, 2020 .

High‐Resolution Characterization of Linkage Disequilibrium Structure and Selection of Tagging Single Nucleotide Polymorphisms: Application to the Cholesteryl Ester Transfer Protein Gene

B. Horne, N. Camp, J. Carlquist, 2006, Annals of human genetics.

Chronic infection and coronary atherosclerosis. Will the hypothesis ever really pan out?

J. Muhlestein, 2011, Journal of the American College of Cardiology.

Fasting and other health influences.

B. Horne, H. May, D. Lappé, 2009, The American journal of cardiology.

Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy.

J. Muhlestein, B. Whisenant, W. Barry, 2003, Catheterization and cardiovascular interventions.

Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation

B. Horne, H. May, D. Lappé, 2018, Open Heart.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

Use of Wearable Technologies for Early Diagnosis and Management of Acute Coronary Syndromes and Arrhythmias

J. Muhlestein, V. Le, 2018, Current Cardiovascular Risk Reports.

Smartphone ECG for evaluation of ST-segment elevation myocardial infarction (STEMI): Design of the ST LEUIS International Multicenter Study.

Benjamin Chisum, Brianna S. Ronnow, T. Bunch, 2017, Journal of electrocardiology.

Patients Treated with Catheter Ablation for Atrial Fibrillation have Long-Term Renal Function Similar to Patients without Atrial Fibrillation

H. May, T. Bair, Jeffrey L. Anderson, 2014 .

Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowing.

B. Horne, D. Lappé, R. Pearson, 2007, The American journal of cardiology.

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

B. Horne, H. May, J. Carlquist, 2023, Frontiers in cardiovascular medicine.

Abstract 11700: Higher Plasma EPA, EPA/AA and DHA Levels Are Associated With Lower Incident MACE Both in Those With and Without Angiographic CAD

B. Horne, D. Lappé, T. Bair, 2019 .

Restenosis: A Guide to Therapy

J. Muhlestein, 2001 .

EFFECT OF ANTIHYPERTENSIVE CLASS ON VISIT-TO-VISIT OFFICE BLOOD PRESSURE VARIABILITY AND ITS EFFECT ON ALL-CAUSE MORTALITY

B. Horne, H. May, J. Muhlestein, 2018 .

Genome-Wide Significance and Replication of the Chromosome 12p11.22 Locus Near the PTHLH Gene for Peripartum Cardiomyopathy

B. Horne, H. May, J. Muhlestein, 2011, Circulation. Cardiovascular genetics.

Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort

B. Horne, H. May, Brianna S. Ronnow, 2022, BMJ Open.

Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study.

B. Horne, J. Carlquist, Jeffrey L. Anderson, 2007, American heart journal.

Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients.

Benjamin D. Horne, Colleen Roberts, Joseph B. Muhlestein, 2008, Journal of cardiac failure.

Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.

G. Dangas, J. Muhlestein, M. Effron, 2017, The Canadian journal of cardiology.

Common Variants in 6 Lipid-Related Genes Discovered by High-Resolution DNA Melting Analysis and Their Association with Plasma Lipids.

B. Horne, N. Camp, J. Carlquist, 2011, Journal of clinical & experimental cardiology.

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

H. May, D. Lappé, T. Bair, 2014, JAMA.

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.

W. Kraus, B. Horne, Jeffrey L. Anderson, 2008, Journal of the American College of Cardiology.

Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

B. Horne, H. May, D. Lappé, 2011, American heart journal.

Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients

J. Muhlestein, 2009, Thrombosis and Haemostasis.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

ASSOCIATION BETWEEN BASELINE PLASMA RENIN ACTIVITY AND CLINICAL OUTCOMES IN NON-HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE: PP.24.458

B. Horne, H. May, T. Bair, 2010 .

Abstract 1133: Association Between Baseline Plasma Renin Activity and Risk of Cardiovascular Events in Women With Coronary Artery Disease

B. Horne, H. May, T. Bair, 2009 .

Warfarin Is Not Needed in Low‐Risk Patients Following Atrial Fibrillation Ablation Procedures

H. May, D. Lappé, T. Bair, 2009, Journal of cardiovascular electrophysiology.

CORONARY ARTERY DISEASE Original Studies Usage Patterns and 2-Year Outcomes With the TAXUS Express Stent: Results of the US ARRIVE 1 Registry

D. Baim, J. Muhlestein, J. Lasala, 2008 .

Novel Stratification of Mortality Risk by Kidney Disease Stage

B. Horne, T. Bair, Jeffrey L. Anderson, 2016, American Journal of Nephrology.

B. Horne, J. Carlquist, J. Muhlestein, 1999, Circulation.

Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trial

N. Paynter, P. Ridker, B. Horne, 2015, European journal of preventive cardiology.

Antibiotic therapy for treatment of Chlamydia to prevent coronary heart disease events

J. Muhlestein, 2000, Current atherosclerosis reports.

HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

P. Joshi, H. May, Jeffrey L. Anderson, 2015, European heart journal.

Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography.

H. May, Jeffrey L. Anderson, M. Connelly, 2016, Clinical biochemistry.

Randomized Secondary Prevention Trial of Azithromycin in Patients With Coronary Artery Disease: Primary Clinical Results of the ACADEMIC Study

B. Horne, J. Carlquist, R. Pearson, 2000, Circulation.

Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.

J. Carlquist, T. Bair, S. P. Elmer, 1999, Journal of the American College of Cardiology.

Long-Term Natural History of Adult Wolff–Parkinson–White Syndrome Patients Treated With and Without Catheter Ablation

H. May, T. Bair, M. Cutler, 2015, Circulation. Arrhythmia and electrophysiology.

Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE

P. Libby, H. May, J. Muhlestein, 2023, Frontiers in cardiovascular medicine.

B. Horne, H. May, D. Lappé, 2007, Circulation.